Editor in Chief, @FierceBiotech, @FierceHealth and @FiercePharma. Write always, edit everything, run with dogs, ski the East

Joined March 2009
20 Photos and videos
Tracy Staton retweeted
Live from BIO 2022! Here's a short excerpt from @maxonwifi's sit-down interview with @BayerPharma president @guth_sebastian.
1
4
Nice interview with FDA's Richard Pazdur from @FierceBiotech and @Angus_Fierce as we head into #AACR2022 this weekend.
Check out our exclusive interview with FDA oncology chief Richard Pazdur: “People want to take risks in oncology. I’ve been through this with family members and friends; it’s like ‘Doc, give it to me.’” #acceleratedapproval #oncology fiercebiotech.com/biotech/fd…
2
One of my favorite parts of @FiercePharma's drug name Madness is the "sounds like" critiques from our readers. Airport wifi, fire-breathing dragon, Megan Thee Stallion duet partner ... and more.
Even if your pick doesn't win #FierceMadness, we're sharing our favorite comments from voters here in our Fierce Hall of Fame. Check out the comments below, and ICYMI here's our running coverage of this year's challenge. loom.ly/VRZG5Kc
Last day to vote in this round of @FiercePharma's 2022 #FierceMadness drug name tournament! Check out the bracket below and then vote here: mollywalker8418.survey.fm/fi…
1
Really proud of the biotech, healthcare and pharma editorial teams here at Fierce. We have a raft of finalist nods in the Neal awards, plus more in the Azbees. Check out both threads below for the stories and news coverage that rated.
But that's not all! Fierce Biotech has also been named as a finalist for 2 Jesse H. Neal Awards, including Best Media Brand in the Overall Editorial Excellence category! siia.net/siia-announces-fina…
3
Tracy Staton retweeted
Fierce Biotech has been named as a finalist for 3 regional and 2 national Azbee Awards of Excellence! See our award-winning coverage below asbpe.org/news/2022/03/09/as…

1
2
5
Tracy Staton retweeted
It’s deja vu all over again. These are the questions that the FDA Advisory Committee unanimously decided more than a year ago had not been answered for aducanumab. The FDA’s accelerated approval has been a pointless disaster for people with Alzheimer’s and our Field.
Replying to @tricia_neuman
@CMSgov is looking for the trials to address two fairly fundamental questions: does it work to affect a decline in cognition and function and does it increase significant adverse effects?
4
13
55
Tracy Staton retweeted
$ABBV is down 10% after the FDA said makers of JAK inhibitors must add warnings of heart conditions, blood clots, cancer and death to their labels. This also impacts $PFE and $LLY. This doesn't pertain to drugs from $INCY and $BMY, however.
3
15
29
Tracy Staton retweeted
8 Jun 2021
Update on the elephants: they are still on the outskirts of Kunming, and have the most adorable sleeping formation
18
283
1,216
Tracy Staton retweeted
New rule....investors start preferring public AdComs. No more cheering when a drug doesn't get one. It's the strongest part of the regulatory process that brings out truth. Keeps companies honest.
7
6
79
Tracy Staton retweeted
My 5 "perfect storm" worries for Texas: 1. "No vaccines" we still haven't picked up the pace post Ice Harvey, ranking near bottom for vaccinations. 2. No masks 3. Rising B..1.1.7 variant based on new Houston Health wastewater data. 4. Slight rise in positivity 5. Spring Break
41
207
630
Scouting for smart journalists who'd like to make a difference covering the science and business of the pandemic. Medtech, biotech, pharma—we're an ambitious and growing team. #journojobs posts link below, or DM me: careers-questex.icims.com/jo…

2
1
Tracy Staton retweeted
Yikes! The number of clinical trials for #oncology #drugs dropped by 60% during #COVID19 pandemic period @Medidata @JAMANetworkOpen drugch.nl/3ud4hDE Fewer new therapies will be launched in coming years. That's the wrong way to curb drug spending.
2
5
5
Tracy Staton retweeted
The White House has resumed the search for a permanent FDA commissioner in the face of opposition from D senators to Janet Woodcock. A final decision has not been made, but Woodcock's chances are slipping. Josh Sharfstein, is no longer being considered. biocentury.com/article/63452…
7
13
Fierce is hiring! Senior editors and staff writers covering biotech, medtech and pharma. Look for job posts on Journalism Jobs and via our corporate job portal. careers-questex.icims.com/jo… #journojobs #journalismjobs @journosofcolor @WritersofColor
2
1